Background
Coronavirus disease (COVID-19) started in China as a severe pneumonia of unknown cause in late 2019 and quickly spread throughout the world with human-to-human transmission. COVID-19 was declared a pandemic in the first quarter of 2020 by the World Health Organization (WHO) and has caused a significant loss of human lives and financial resources worldwide.(1) The pandemic is far from being over and has compromised even the most developed countries’ healthcare systems. There are various risk factors for getting severe COVID-19 infection, such as patients’ age, co-morbidities such as diabetes, cardiovascular and chronic respiratory disorders (2-4). However, the role of immunosuppression therapy is still not clear.(5) Use of the immunosuppressant medication in post-renal transplant patients may increase the risk of various viral infections.(6)
Adequate literature is not available from the region regarding the impact of COVID-19 infection in post-renal transplant patients, whereas the international literature is limited to a case series with contrast findings and conclusions.(7)
This case series explores the occurrence of COVID-19 infection in post-renal transplant patients, their risk factors, severity, course of the disease, and outcomes.